Aya Safieddine

XEIA Venture Partners thesis

NeuroBionics > advancing Human 3 with minimally invasive brain-computer interfaces Superpower > advancing Human 3 with concierge medicine for all Motif > advancing Human 3 with neurotech that ends depression Mindstate Design Labs > advancing Human 3 with precision psychedelic therapies XEIA invests in life sciences, AI, hardware, software, deep tech & health tech to advance Human 3 - the new epoch of health, wellbeing and performance Learn more

Sector and stage focus

• Seed: Pharmaceuticals, BioTech, Therapeutics, Health & Hospital Services
• general: Los Angeles / Southern California
• Pre-seed: Pharmaceuticals, BioTech, Health & Hospital Services, Therapeutics

Is Aya Safieddine a fit for your round?

Upload your pitch deck and see whether Aya Safieddine appears in your top 20 matches.